{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:26:43Z","timestamp":1792196803569,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.psyneuen.2019.104371","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T19:41:55Z","timestamp":1562182915000},"page":"104371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Kynurenine metabolism and inflammation-induced depressed mood: A human experimental study"],"prefix":"10.1016","volume":"109","author":[{"given":"Jennifer L.","family":"Kruse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua Hyong-Jin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Olmstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kym","family":"Faull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi I.","family":"Eisenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2019.104371_bib0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/cap.2015.0147","article-title":"The relationship between plasma cytokine levels and response to selective serotonin reuptake inhibitor treatment in children and adolescents with depression and\/or anxiety disorders","volume":"26","author":"Amitai","year":"2016","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2019.104371_bib0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/pon.564","article-title":"A POMS short form for cancer patients: psychometric and structural evaluation","volume":"11","author":"Baker","year":"2002","journal-title":"Psychooncology"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbi.2014.07.012","article-title":"A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality","volume":"43","author":"Bay-Richter","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2019.104371_bib0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnins.2014.00012","article-title":"Kynurenines in CNS disease: regulation by inflammatory cytokines","volume":"8","author":"Campbell","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.psyneuen.2019.104371_bib0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","article-title":"Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions","volume":"26","author":"Capuron","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biopsych.2010.12.006","article-title":"Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms","volume":"70","author":"Capuron","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0035","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41386-018-0038-4","article-title":"Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia","volume":"43","author":"Chiappelli","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0040","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41386-019-0316-9","article-title":"Transcriptomic predictors of inflammation-induced depressed mood","volume":"44","author":"Cho","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/7854_2016_6","article-title":"Role of the kynurenine metabolism pathway in inflammation-induced depression: preclinical approaches","volume":"31","author":"Dantzer","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.psyneuen.2019.104371_bib0050","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0055","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.biopsych.2010.06.010","article-title":"Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward","volume":"68","author":"Eisenberger","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0060","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.biopsych.2010.06.010","article-title":"Inflammation-induced\u202f anhedonia: endotoxin reduces ventral striatum responses to reward","volume":"68","author":"Eisenberger","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0065","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","article-title":"Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder","volume":"32","author":"Eller","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0070","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/npp.2012.248","article-title":"Connecting inflammation with glutamate agonism in suicidality","volume":"38","author":"Erhardt","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0075","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood\u2013brain barrier transport of Kynurenines: implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psyneuen.2019.104371_bib0080","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/archpsyc.61.3.310","article-title":"Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry","volume":"61","author":"Gueorguieva","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0085","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.3390\/ijms16047796","article-title":"Inflammatory biomarkers as differential predictors of antidepressant response","volume":"16","author":"Hashimoto","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.psyneuen.2019.104371_bib0090","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1016\/j.neuroimage.2011.10.090","article-title":"Inflammation selectively enhances amygdala activity to socially threatening images","volume":"59","author":"Inagaki","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0095","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41386-018-0259-6","article-title":"Moderators for depressed mood and systemic and transcriptional inflammatory responses: a randomized controlled trial of endotoxin","volume":"44","author":"Irwin","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0100","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.psyneuen.2019.104371_bib0105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies","volume":"135","author":"Kohler","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psyneuen.2019.104371_bib0110","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11597","article-title":"Inflammation and improvement of depression following electroconvulsive therapy in treatment-resistant depression","volume":"79","author":"Kruse","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0115","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","article-title":"Cytokine production and treatment response in major depressive disorder","volume":"22","author":"Lanquillon","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1742-2094-10-87","article-title":"Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors","volume":"10","author":"Lawson","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.psyneuen.2019.104371_bib0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/mp.2016.36","article-title":"The role of adipokines in the rapid antidepressant effects of ketamine. Molecular psychiatry","volume":"22","author":"Machado-Vieira","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1037\/1082-989X.7.1.83","article-title":"A comparison of methods to test mediation and other intervening variable effects","volume":"7","author":"MacKinnon","year":"2002","journal-title":"Psychol. Methods"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0135","series-title":"EITS Manual for the Profile of Mood States","author":"McNair","year":"1971"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbi.2015.11.003","article-title":"Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder","volume":"53","author":"Meier","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2019.104371_bib0145","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/rcm.4013","article-title":"Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"23","author":"Midttun","year":"2009","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.psyneuen.2019.104371_bib0150","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/npp.2013.140","article-title":"Conceptual confluence: the kynurenine pathway as a common target for ketamine and the convergence of the inflammation and glutamate hypotheses of depression","volume":"38","author":"Miller","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0155","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.psyneuen.2015.08.020","article-title":"Trait sensitivity to social disconnection enhances pro-inflammatory responses to a randomized controlled trial of endotoxin","volume":"62","author":"Moieni","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0160","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/npp.2015.17","article-title":"Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression","volume":"40","author":"Moieni","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.psyneuen.2019.104371_bib0165","first-page":"619","article-title":"Sex differences in the relationship between inflammation and reward sensitivity: a randomized controlled trial of endotoxin","volume":"4","author":"Moieni","year":"2019","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0170","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the prevention of depression induced by high-dose interferon alfa","volume":"344","author":"Musselman","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psyneuen.2019.104371_bib0175","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O\u2019Connor","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0180","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.psyneuen.2014.03.013","article-title":"Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?","volume":"45","author":"Quak","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0185","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.psyneuen.2019.104371_bib0190","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-[alpha]: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0200","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/mp.2015.22","article-title":"Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study","volume":"21","author":"Rapaport","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0205","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","article-title":"Cytokine-associated emotional and cognitive disturbances in humans","volume":"58","author":"Reichenberg","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0210","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/mp.2012.125","article-title":"Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder","volume":"18","author":"Rethorst","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0215","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpsychires.2015.05.007","article-title":"Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: evidences from animal and human studies","volume":"68","author":"Reus","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2019.104371_bib0220","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0225","article-title":"The kynurenine pathway: a finger in every pie","author":"Savitz","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2015.02.007","article-title":"Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder","volume":"46","author":"Savitz","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2019.104371_bib0235","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.psyneuen.2019.104371_bib0240","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-2094-8-94","article-title":"Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?","volume":"8","author":"Steiner","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0245","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: a meta-analysis","volume":"25","author":"Strawbridge","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2019.104371_bib0250","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4088\/JCP.12r07694","article-title":"Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis","volume":"73","author":"Udina","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.psyneuen.2019.104371_bib0255","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0260","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/npp.2013.71","article-title":"NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice","volume":"38","author":"Walker","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0265","article-title":"Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice","author":"Walker","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104371_bib0270","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.biopsych.2014.06.021","article-title":"Serum Interleukin-6 is a predictive biomarker for ketamine\u2019s antidepressant effect in treatment-resistant patients with major depression","volume":"77","author":"Yang","year":"2015","journal-title":"Biol. Psychiatry"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453019304500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453019304500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T17:05:08Z","timestamp":1759683908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453019304500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":54,"alternative-id":["S0306453019304500"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104371","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kynurenine metabolism and inflammation-induced depressed mood: A human experimental study","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104371"}}